Show simple item record

dc.contributor.authorBaker, Justin N.
dc.contributor.authorChallinor, Julia
dc.contributor.authorMorrissey, Lisa
dc.contributor.authorFuchs, Joerg
dc.contributor.authorMarcus, Karen
dc.contributor.authorBalduzzi, Adriana
dc.contributor.authorBasset-Salom, Luisa
dc.contributor.authorCaniza, Miguela
dc.contributor.authorKebudi, Rejin
dc.contributor.authorPritchard-Jones, Kathy
dc.contributor.authorSullivan, Richard
dc.contributor.authorHessissen, Laila
dc.contributor.authorSullivan, Michael
dc.contributor.authorBouffet, Eric
dc.contributor.authorRodriguez-Galindo, Carlos
dc.contributor.authorLuna-Fineman, Sandra
dc.contributor.authorKhan, Muhammad Saghir
dc.contributor.authorKearns, Pam
dc.contributor.authorHawkins, Douglas S.
dc.date.accessioned2021-03-02T17:41:21Z
dc.date.available2021-03-02T17:41:21Z
dc.date.issued2020
dc.identifier.citationSullivan M., Bouffet E., Rodriguez-Galindo C., Luna-Fineman S., Khan M. S. , Kearns P., Hawkins D. S. , Challinor J., Morrissey L., Fuchs J., et al., "The COVID-19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI, and St Jude Global", PEDIATRIC BLOOD & CANCER, cilt.67, 2020
dc.identifier.issn1545-5009
dc.identifier.othervv_1032021
dc.identifier.otherav_c8fbf0b6-55e0-4177-9593-eb4a8c4e0eac
dc.identifier.urihttp://hdl.handle.net/20.500.12627/4245
dc.identifier.urihttps://doi.org/10.1002/pbc.28409
dc.description.abstractThe COVID-19 pandemic is one of the most serious global challenges to delivering affordable and equitable treatment to children with cancer we have witnessed in the last few decades. This Special Report aims to summarize general principles for continuing multidisciplinary care during the SARS-CoV-2 (COVID-19) pandemic. With contributions from the leadership of the International Society for Pediatric Oncology (SIOP), Children's Oncology Group (COG), St Jude Global program, and Childhood Cancer International, we have sought to provide a framework for healthcare teams caring for children with cancer during the pandemic. We anticipate the burden will fall particularly heavily on children, their families, and cancer services in low- and middle-income countries. Therefore, we have brought together the relevant clinical leads from SIOP Europe, COG, and SIOP-PODC (Pediatric Oncology in Developing Countries) to focus on the six most curable cancers that are part of the WHO Global Initiative in Childhood Cancer. We provide some practical advice for adapting diagnostic and treatment protocols for children with cancer during the pandemic, the measures taken to contain it (e.g., extreme social distancing), and how to prepare for the anticipated recovery period.
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectHEMATOLOJİ
dc.subjectPEDİATRİ
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectOnkoloji
dc.subjectÇocuk Sağlığı ve Hastalıkları
dc.subjectİç Hastalıkları
dc.subjectHematoloji
dc.titleThe COVID-19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI, and St Jude Global
dc.typeMakale
dc.relation.journalPEDIATRIC BLOOD & CANCER
dc.contributor.departmentRoyal Children''s Hospital Melbourne , ,
dc.identifier.volume67
dc.identifier.issue7
dc.contributor.firstauthorID2281871


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record